 LONDON and RALEIGH, N.C., July 22, 2021 GLOBE NEWSWIRE -- Verona Pharma plc Nasdaq: VRNA Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces that it will report its financial results for the three and six months ended June 30, 2021 on Thursday, August 5, 2021 and host an investment community conference call at 8:30 a.m. EDT 1:30 p.m. BST to discuss these financial results and provide a corporate update. 